ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,651Medicare Part D Prescriptions Filled, Including Refills

Rank: 184 out of 2588

$626K Total Retail Price of All Prescriptions

Rank: 306 out of 2588

442 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 442 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

25% of this provider’s 442 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 12,481 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
HYDROCODONE-ACETAMINOPHEN 624 534 S3 1 7
FUROSEMIDE 564 534 2 5
LISINOPRIL 505 484 3 3
LEVOTHYROXINE SODIUM 392 379 4 2
SIMVASTATIN 390 374 5 1
AMLODIPINE BESYLATE 387 371 6 4
ATENOLOL 371 348 7 14
WARFARIN SODIUM 351 351 8 10
METOPROLOL TARTRATE 340 293 9 9
OMEPRAZOLE 327 300 10 6
METFORMIN HCL 242 204 11 8
DONEPEZIL HCL 242 241 11 22
SERTRALINE HCL 239 205 13 26
POTASSIUM CHLORIDE 214 181 14 15
GABAPENTIN 196 181 15 18
ALENDRONATE SODIUM 193 179 16 21
METOPROLOL SUCCINATE 190 184 17 12
HYDROCHLOROTHIAZIDE 182 158 18 13
TRAMADOL HCL 176 150 19 19
PRAVASTATIN SODIUM 160 159 20 16
NAMENDA 158 158 21 32
TRIAMTERENE-HCTZ 148 148 22 46
ATORVASTATIN CALCIUM 147 141 23 11
FENTANYL 147 111 S2 23 78
ENALAPRIL MALEATE 143 142 25 31
DIGOXIN 138 131 26 38
CITALOPRAM HBR 134 123 27 27
PREDNISONE 128 119 28 42
MELOXICAM 120 119 29 51
CLOPIDOGREL 120 109 29 30
LANTUS 119 103 31 47
TAMSULOSIN HCL 106 106 32 23
OXYBUTYNIN CHLORIDE ER 92 80 33 85
AZITHROMYCIN 91 86 34 45
GLIPIZIDE ER 91 78 34 73
CARVEDILOL 90 90 36 20
CARBIDOPA-LEVODOPA 88 88 37 83
LOVASTATIN 88 76 37 34
CIPROFLOXACIN HCL 87 86 39 82
PANTOPRAZOLE SODIUM 87 75 39 28
PLAVIX 84 79 41 43
SPIRONOLACTONE 83 79 42 58
NOVOLOG 79 75 43 103
NIFEDIPINE ER 79 79 43 59
GLIPIZIDE 79 74 43 44
FLUOXETINE HCL 76 76 46 92
MIRTAZAPINE 76 69 46 63
LEVETIRACETAM 75 40 48 90
FAMOTIDINE 75 62 48 36
FINASTERIDE 71 71 50 97
TERAZOSIN HCL 70 70 51 137
PAROXETINE HCL 70 70 51 71
ESCITALOPRAM OXALATE 68 59 53 68
KLOR-CON M20 68 64 53 52
ALLOPURINOL 66 56 55 33
MEGESTROL ACETATE 63 56 R 56 169
CLOTRIMAZOLE-BETAMETHASONE 60 58 57 155
CEPHALEXIN 58 55 58 138
CYMBALTA 55 55 59 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.